Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Koster

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|April 7, 1994
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study GroupJ S Duchin, F T Koster, C J Peters, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
Complicated Carriage with Methicillin-Resistant Staphylococcus aureus: Evaluation of the Effectiveness of Decolonization Regimens Advised in the Dutch National GuidelineA C Westgeest, E F Schippers, N M Delfos, et al.
Human Pathology|January 1, 1995
Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agentK B Nolte, R M Feddersen, K Foucar, et al.
Respiration; International Review of Thoracic Diseases|June 13, 2024
Endobronchial Valves in Treatment of Persistent Air Leak: European Case-Series Study and Best Practice Recommendations - From an Expert PanelIllaa Smesseim, Louis-Vincent Morin-Thibault, Felix J F Herth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North AmericaGregory J Mertz, Lil Miedzinski, Diane Goade, et al.
Journal of Thrombosis and Haemostasis : JTH|March 17, 2010
Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP levelM J Agterof, R E G Schutgens, R J Snijder, et al.
Carbohydrate Polymers|March 26, 2022
The level and distribution of methyl-esters influence the impact of pectin on intestinal T cells, microbiota, and Ahr activationM Beukema, É Jermendi, M M P Oerlemans, et al.
BMJ Open|June 29, 2018
A Reduction in Time with Electronic Monitoring In Stroke (ARTEMIS): study protocol for a randomised multicentre trialGaia T Koster, T Truc My Nguyen, Adrien E D Groot, et al.
The Journal of Infectious Diseases|April 1, 1996
Epidemiologic linkage of rodent and human hantavirus genomic sequences in case investigations of hantavirus pulmonary syndromeB Hjelle, N Tórrez-Martínez, F T Koster, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 22, 2014
Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infectionW E van der Starre, S M Zunder, A M Vollaard, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|April 7, 1994
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study GroupJ S Duchin, F T Koster, C J Peters, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
Complicated Carriage with Methicillin-Resistant Staphylococcus aureus: Evaluation of the Effectiveness of Decolonization Regimens Advised in the Dutch National GuidelineA C Westgeest, E F Schippers, N M Delfos, et al.
Human Pathology|January 1, 1995
Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agentK B Nolte, R M Feddersen, K Foucar, et al.
Respiration; International Review of Thoracic Diseases|June 13, 2024
Endobronchial Valves in Treatment of Persistent Air Leak: European Case-Series Study and Best Practice Recommendations - From an Expert PanelIllaa Smesseim, Louis-Vincent Morin-Thibault, Felix J F Herth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North AmericaGregory J Mertz, Lil Miedzinski, Diane Goade, et al.
Journal of Thrombosis and Haemostasis : JTH|March 17, 2010
Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP levelM J Agterof, R E G Schutgens, R J Snijder, et al.
Carbohydrate Polymers|March 26, 2022
The level and distribution of methyl-esters influence the impact of pectin on intestinal T cells, microbiota, and Ahr activationM Beukema, É Jermendi, M M P Oerlemans, et al.
BMJ Open|June 29, 2018
A Reduction in Time with Electronic Monitoring In Stroke (ARTEMIS): study protocol for a randomised multicentre trialGaia T Koster, T Truc My Nguyen, Adrien E D Groot, et al.
The Journal of Infectious Diseases|April 1, 1996
Epidemiologic linkage of rodent and human hantavirus genomic sequences in case investigations of hantavirus pulmonary syndromeB Hjelle, N Tórrez-Martínez, F T Koster, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 22, 2014
Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infectionW E van der Starre, S M Zunder, A M Vollaard, et al.
Pageof 10